Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.

KOOL

Cesca Therapeutics (KOOL)

Cesca Therapeutics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:KOOL
DateHeureSourceTitreSymboleSociété
31/10/201911h30PR Newswire (US)Cesca Therapeutics To Change Name And Ticker Symbol To Reflect New Strategic FocusNASDAQ:KOOLCesca Therapeutics Inc
24/10/201914h30PR Newswire (US)Cesca Therapeutics to Present at the Dawson James Securities 5th Annual Small Cap Growth ConferenceNASDAQ:KOOLCesca Therapeutics Inc
22/10/201916h01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KOOLCesca Therapeutics Inc
22/10/201912h30PR Newswire (US)Cesca Therapeutics Forms Joint Venture with Healthbanks Biotech (USA) to Provide Immune Cell Banking and Cell Processing Serv...NASDAQ:KOOLCesca Therapeutics Inc
14/10/201914h30PR Newswire (US)Cesca Therapeutics To Present At The 2019 Bio Investor ForumNASDAQ:KOOLCesca Therapeutics Inc
02/10/201914h30PR Newswire (US)Cesca Therapeutics Announces Receipt Of $2 Million Upfront Distribution FeeNASDAQ:KOOLCesca Therapeutics Inc
25/09/201916h25PR Newswire (US)ThermoGenesis Reports Performance Evaluations of X-Series® Cell Processing DevicesNASDAQ:KOOLCesca Therapeutics Inc
24/09/201920h35Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:KOOLCesca Therapeutics Inc
19/09/201900h42Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KOOLCesca Therapeutics Inc
12/09/201923h08Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:KOOLCesca Therapeutics Inc
09/09/201914h30PR Newswire (US)Cesca Therapeutics And ThermoGenesis Announce Major Global Distribution Agreement For The Company's X-Series® ProductsNASDAQ:KOOLCesca Therapeutics Inc
03/09/201914h30PR Newswire (US)Cesca Therapeutics To Present At The H.C. Wainwright 21st Annual Global Investment ConferenceNASDAQ:KOOLCesca Therapeutics Inc
13/08/201922h35Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:KOOLCesca Therapeutics Inc
13/08/201922h05PR Newswire (US)Cesca Therapeutics Announces Improved Second Quarter 2019 Financial Results and Provides Corporate UpdateNASDAQ:KOOLCesca Therapeutics Inc
06/08/201914h30PR Newswire (US)Cesca Therapeutics To Announce Financial Results For The Second Quarter Ended June 30, 2019 And Host A Conference Call On Aug...NASDAQ:KOOLCesca Therapeutics Inc
23/07/201914h30PR Newswire (US)America's Largest Cord Blood Bank, CBR®, Upgrading to ThermoGenesis' AXP® II SystemNASDAQ:KOOLCesca Therapeutics Inc
11/07/201922h35Edgar (US Regulatory)Specialized Disclosure Report (sd)NASDAQ:KOOLCesca Therapeutics Inc
26/06/201914h30PR Newswire (US)Cesca Therapeutics Regains Nasdaq Listing ComplianceNASDAQ:KOOLCesca Therapeutics Inc
25/06/201914h30PR Newswire (US)Cordlife to Use the ThermoGenesis AXP® II System for Rapid Processing of Cord Blood Units in IndiaNASDAQ:KOOLCesca Therapeutics Inc
18/06/201914h30PR Newswire (US)ThermoGenesis Receives Health Canada Approval of its Next-Generation AXP® II System for Cord Blood ProcessingNASDAQ:KOOLCesca Therapeutics Inc
05/06/201914h30PR Newswire (US)ThermoGenesis to Participate in The Orthobiologic Institute's 10th Annual PRP & Regenerative Medicine SymposiumNASDAQ:KOOLCesca Therapeutics Inc
04/06/201918h00PR Newswire (US)Cesca Therapeutics Announces 1-for-10 Reverse Split Of Common StockNASDAQ:KOOLCesca Therapeutics Inc
31/05/201912h01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:KOOLCesca Therapeutics Inc
16/05/201912h04Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:KOOLCesca Therapeutics Inc
14/05/201922h05PR Newswire (US)Cesca Therapeutics Announces First Quarter 2019 Financial Results And Provides Corporate UpdateNASDAQ:KOOLCesca Therapeutics Inc
13/05/201921h35Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:KOOLCesca Therapeutics Inc
07/05/201914h30PR Newswire (US)Cesca Therapeutics to Announce Financial Results for the First Quarter Ended March 31, 2019 and Host a Conference Call on May...NASDAQ:KOOLCesca Therapeutics Inc
30/04/201921h44Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:KOOLCesca Therapeutics Inc
22/04/201912h03Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)NASDAQ:KOOLCesca Therapeutics Inc
17/04/201914h00PR Newswire (US)ThermoGenesis Releases its Enhanced X-MINI® CD3 Selection Kit for the Research MarketNASDAQ:KOOLCesca Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:KOOL